Point-of-care Molecular Diagnostics Market would be valued US$ 11.1 Billion by 2033 at a CAGR of 9.7% | FMI Study
The rapid and accurate diagnosis of diseases is transforming patient care, and the Point-of-care Molecular
Global Point-of-care Molecular Diagnostics Industry Surges at 9.7% CAGR, Anticipating a Whopping US$11.1 Billion Landscape by 2033 | FMI Insights
The Global Point-Of-Care Molecular Diagnostics Industry is predicted to secure a valuation of US$ 4.4 billion in